Briefcases -- Drugs -- NUPLAZID (pimavanserin) by ACADIA Pharmaceuticals, Inc.

NUPLAZID (pimavanserin) by ACADIA Pharmaceuticals, Inc.

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. Single Event Case Filings
  2. Media References
  3. FDA Regulatory Materials

Quick Access

  1. NUPLAZID (pimavanserin) FDA Approval Letter ORIG-1 to Acadia Pharmaceuticals (April 29, 2016)
  2. NUPLAZID (pimavanserin) FDA Labels Approval ORIG-1 (April 29, 2016)
  3. NUPLAZID (pimavanserin) FDA Label Package Insert SUPPL-1 (October 17, 2017)
  4. NUPLAZID (pimavanserin) FDA Label Package Insert SUPPL-2 (March 4, 2018)
  5. NUPLAZID (pimavanserin) FDA Label Package Insert SUPPL-4 (March 4, 2018)
  6. NUPLAZID (pimavanserin) FDA Approval Summary (April 29, 2016)
  7. NUPLAZID (pimavanserin) FDA Approval Summary Files and Labels (June 3, 2016)